Hai Qian

4.4k total citations
203 papers, 3.5k citations indexed

About

Hai Qian is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hai Qian has authored 203 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 44 papers in Oncology and 37 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hai Qian's work include Diabetes Treatment and Management (34 papers), Drug Transport and Resistance Mechanisms (23 papers) and Pancreatic function and diabetes (20 papers). Hai Qian is often cited by papers focused on Diabetes Treatment and Management (34 papers), Drug Transport and Resistance Mechanisms (23 papers) and Pancreatic function and diabetes (20 papers). Hai Qian collaborates with scholars based in China, United States and Austria. Hai Qian's co-authors include Wenlong Huang, Qianqian Qiu, Wei Shi, Zheng Li, Chunlei Tang, Shu Chen, Yuxuan Dai, Chunxia Liu, Xin Deng and Miaobo Pan and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and ACS Applied Materials & Interfaces.

In The Last Decade

Hai Qian

196 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai Qian China 31 1.7k 584 581 572 432 203 3.5k
Mutasem O. Taha Jordan 34 1.7k 1.0× 1.1k 1.9× 282 0.5× 379 0.7× 153 0.4× 185 3.9k
Zhiyu Li China 43 3.1k 1.8× 755 1.3× 387 0.7× 974 1.7× 316 0.7× 291 6.0k
Florence Lefranc Belgium 42 2.5k 1.4× 923 1.6× 307 0.5× 666 1.2× 550 1.3× 108 6.3k
Paolo Paoli Italy 34 2.2k 1.3× 565 1.0× 412 0.7× 540 0.9× 177 0.4× 116 4.2k
Gabriella Castoria Italy 38 3.3k 1.9× 298 0.5× 698 1.2× 1.6k 2.8× 231 0.5× 99 6.7k
Joanna E. Burdette United States 36 2.2k 1.3× 299 0.5× 343 0.6× 550 1.0× 162 0.4× 182 4.8k
Yinglan Zhao China 40 2.9k 1.7× 542 0.9× 131 0.2× 730 1.3× 199 0.5× 160 5.4k
Carlotta Granchi Italy 32 2.3k 1.4× 432 0.7× 202 0.3× 630 1.1× 278 0.6× 109 4.1k
Filippo Minutolo Italy 38 2.6k 1.5× 1.1k 1.9× 218 0.4× 770 1.3× 264 0.6× 158 5.2k
Min You United States 39 2.6k 1.5× 336 0.6× 205 0.4× 675 1.2× 228 0.5× 98 5.0k

Countries citing papers authored by Hai Qian

Since Specialization
Citations

This map shows the geographic impact of Hai Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Qian more than expected).

Fields of papers citing papers by Hai Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Qian. The network helps show where Hai Qian may publish in the future.

Co-authorship network of co-authors of Hai Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Qian. A scholar is included among the top collaborators of Hai Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Qian. Hai Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Hongyu, et al.. (2025). Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications. Chinese Journal of Natural Medicines. 23(1). 31–42. 4 indexed citations
2.
Liu, Chunxia, Wenxin Wang, Haoyang Chen, et al.. (2025). Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect. European Journal of Medicinal Chemistry. 292. 117649–117649.
3.
Liu, Shuyu, Kai Qin, Jiahao Du, et al.. (2025). Design, synthesis and biological activity of novel pyrimidine piperazine ureas as μ-opioid and TRPV1 dual-target ligands for pain management. European Journal of Medicinal Chemistry. 292. 117656–117656. 1 indexed citations
4.
Liu, Chunxia, Wenxin Wang, Shiyu Zhao, et al.. (2024). Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects. Bioorganic & Medicinal Chemistry. 107. 117750–117750. 5 indexed citations
5.
Zhang, Ping, Yuyan Yang, Wei Shi, et al.. (2024). Highly Potent and Intestine Specific P‐Glycoprotein Inhibitor to Enable Oral Delivery of Taxol. Angewandte Chemie International Edition. 63(45). e202412649–e202412649. 5 indexed citations
6.
Zhou, Jiaqi, Jialing Wang, Zhipeng Hu, et al.. (2023). Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors. European Journal of Medicinal Chemistry. 264. 116032–116032. 1 indexed citations
7.
Hensley, Patrick J., Jieming Li, Yang Zhang, et al.. (2020). Integrin-associated CD151 is a suppressor of prostate cancer progression.. PubMed Central. 12(4). 1428–1442. 10 indexed citations
8.
Liu, Tingting, Qianqian Gao, Bobo Yang, et al.. (2020). Differential susceptibility of PC12 and BRL cells and the regulatory role of HIF-1α signaling pathway in response to acute methylmercury exposure under normoxia. Toxicology Letters. 331. 82–91. 9 indexed citations
10.
Liu, Yan, Chen Liao, Jiaqi Zhou, et al.. (2018). Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1. Bioorganic & Medicinal Chemistry. 26(15). 4567–4573. 13 indexed citations
12.
Ge, Liang, Xinru You, Keqing Huang, et al.. (2017). Screening of novel RGD peptides to modify nanoparticles for targeted cancer therapy. Biomaterials Science. 6(1). 125–135. 33 indexed citations
13.
Pan, Miaobo, Jian Cui, Chen Liao, et al.. (2017). Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors. Bioorganic & Medicinal Chemistry. 25(15). 4194–4202. 10 indexed citations
15.
Qian, Hai. (2013). Inspection of traveling wave fault location equipment based on the historical fault waveforms. Power System Protection and Control. 1 indexed citations
16.
Zhang, Ye, Hai Qian, Suhua Wang, et al.. (2010). [Time-course effect and region-specificity of endoplasmic reticulum stress in rat brains acutely exposed by methylmercury].. PubMed. 39(3). 271–4. 2 indexed citations
17.
Qian, Hai. (2009). A Review of Comprehensive Index Methods in Water Quality Assessment. Huanjing yu zhiye yixue. 2 indexed citations
18.
Qian, Hai. (2008). Research on the Development Period of Over-wintering Larvae of Different Geographic Populations of Asian Corn Borer. Hubei nongye kexue. 7 indexed citations
19.
Qian, Hai. (2003). On Administration Liability during the Period of Social Transition. Journal of Shanghai University (English Edition). 1 indexed citations
20.
Qian, Hai. (2002). The Effect of Hormones on Callus Induction and Plantlet Regeneration of Tall Fescue (Festuca arundinacea).. Annual economic survey .../Annual economic survey - Central Bank of Trinidad and Tobago. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026